Ramamourthy Gopal, Arias Mauricio, Nguyen Leonard T, Ishida Hiroaki, Vogel Hans J
Biochemistry Research Group, Department of Biological Sciences, University of Calgary, Calgary, AB T2N 1N4, Canada.
Microorganisms. 2019 Jan 8;7(1):8. doi: 10.3390/microorganisms7010008.
Human macrophage inflammatory protein 3α (MIP-3α), also known as CCL20, is a 70 amino acid chemokine that selectively binds and activates chemokine receptor 6 (CCR6). This chemokine is responsible for inducing the migration of immature dendritic cells, effector, or memory T-cells, and B-cells. Moreover, the MIP-3α protein has been shown to display direct antimicrobial, antiviral and antiprotozoal activities. Because of the potential therapeutic uses of this protein, the efficient production of MIP-3α is of great interest. However, bacterial recombinant production of the MIP-3α protein has been limited by the toxicity of this extremely basic protein (pI 9.7) toward prokaryotic cells, and by solubility problems during expression and purification. In an attempt to overcome these issues, we have investigated the bacterial recombinant expression of MIP-3α by using several common expression and fusion tags, including 6× histidine (His), small ubiquitin modifier protein (SUMO), thioredoxin (TRX), ketosteroid isomerase (KSI), and maltose binding protein (MBP). We have also evaluated a recently introduced calmodulin (CaM)-tag that has been used for the effective expression of many basic antimicrobial peptides (AMPs). Here, we show that the CaM fusion tag system effectively expressed soluble MIP-3α in the cytoplasm of with good yields. Rapid purification was facilitated by the His-tag that was integrated in the CaM-fusion protein system. Multidimensional nuclear magnetic resonance (NMR) studies demonstrated that the recombinant protein was properly folded, with the correct formation of disulfide bonds. In addition, the recombinant MIP-3α had antibacterial activity, and was shown to inhibit the formation of biofilms.
人巨噬细胞炎性蛋白3α(MIP-3α),也称为CCL20,是一种由70个氨基酸组成的趋化因子,它能选择性地结合并激活趋化因子受体6(CCR6)。这种趋化因子负责诱导未成熟树突状细胞、效应T细胞或记忆T细胞以及B细胞的迁移。此外,MIP-3α蛋白已被证明具有直接的抗菌、抗病毒和抗原虫活性。由于这种蛋白具有潜在的治疗用途,因此高效生产MIP-3α备受关注。然而,MIP-3α蛋白的细菌重组生产受到这种极端碱性蛋白(pI 9.7)对原核细胞的毒性以及表达和纯化过程中的溶解性问题的限制。为了克服这些问题,我们通过使用几种常见的表达和融合标签,包括6×组氨酸(His)、小泛素修饰蛋白(SUMO)、硫氧还蛋白(TRX)、酮类固醇异构酶(KSI)和麦芽糖结合蛋白(MBP),研究了MIP-3α的细菌重组表达。我们还评估了最近引入的钙调蛋白(CaM)标签,该标签已用于许多碱性抗菌肽(AMP)的有效表达。在这里,我们表明CaM融合标签系统在细胞质中有效地表达了可溶性MIP-3α,产量很高。CaM融合蛋白系统中整合的His标签便于快速纯化。多维核磁共振(NMR)研究表明,重组蛋白折叠正确,二硫键形成正确。此外,重组MIP-3α具有抗菌活性,并被证明能抑制生物膜的形成。